Kembali
KLBF - Kalbe Farma

KLBF — To manage the impact of IDR volatility

13 September 2024

KLBF — To manage the impact of IDR volatility Kalbe Farma (KLBF) acknowledges that the volatility of the rupiah against the USD significantly affects its cost of goods sold due to its reliance on imported raw materials. To mitigate this, KLBF employs strategies like product mix adjustments and price management to safeguard margins. Additionally, KLBF is actively seeking local substitutes for imported materials and enhancing domestic production capabilities. KLBF has also formed a joint venture with China's Livzon Pharmaceutical Group to build a pharmaceutical raw material facility, aiming to reduce import dependence. (Source : Bisnis Indonesia)

Related Research

Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 Agustus 2025 Lihat Detail
Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 Mei 2022 Lihat Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 Agustus 2022 Lihat Detail